Bio Key International INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
OQB
BIO-key International announces its 2026 Annual Meeting of Stockholders, scheduled for September 3, 2026, to elect directors, ratify auditors, and vote on executive compensation.
OQB
BIO-key International, Inc. is calling a special meeting for stockholders to approve a reverse stock split to regain compliance with Nasdaq's minimum bid price requirement.
OQB
BIO-key International, Inc. has filed its definitive proxy statement for its 2025 Annual Meeting of Stockholders, seeking approval for the election of five directors, ratification of its independent auditor, an advisory vote on executive compensation, and amendments to its 2023 Stock Incentive Plan and 2021 Employee Stock Purchase Plan.
OQB
BIO-key International will hold its 2024 Annual Meeting of Stockholders on August 22, 2024, to vote on director elections, auditor ratification, executive compensation, and other matters.